1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow AL101: new trials by email Literature Review of AL101 trials Research Report on AL101
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study Of AL101In Patients With Adenoid Cystic Carcinoma (ACC) Bearing Activating Notch Mutations AL101 - Adenoid Cystic Carcinoma | Phase 2 | Completed | Ayala Pharmaceuticals, Inc, | 87 | 2018-12-14 | 2024-01-31 |
Ayala Pharmaceuticals, Inc, (1)
Canada (1) · France (1) · Israel (1) · Netherlands (1) · United Kingdom (1) · United States (1)